These publications were authored or co-authored by Quest Diagnostics staff.
Utility of IgM/IgG ratio and IgG avidity for distinguishing primary and secondary dengue virus infections using sera collected more than 30 days after disease onset.Authors: Prince HE, Yeh C, Lape-Nixon M.
Clin Vaccine Immunol. 2011;18:1951-1956.
Dengue virus immunoglobulin M detection in a reference laboratory setting during the 2010 dengue virus outbreak on Caribbean islands.Authors: Prince HE, Matud JL, Lieberman JM.
Clin Vaccine Immunol. 2011;18:1104-1107.
Primary and probable secondary dengue virus (DV) infection rates in relation to age among DV IgM-positive patients residing in the United States mainland versus the Caribbean islands.Authors: Prince HE, Yeh C, Lape-Nixon M.
Clin Vaccine Immunol. 2012;19:105-108.
Ubiquitin-proteasome profiling for enhanced detection of hepatocellular carcinoma in patients with chronic liver disease.Authors: Qu KZ, Zhang K, Ma W, Li H, Wang X, Zhang X, Giles F, Lai M, Afdhal NH, Albitar M.
J Gastroenterol Hepatol. 2011;26:751-758.
J Clin Gastroenterol. 2011;45:355-360.